Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem. 2008 May 15;16(10):5653-64. Epub 2008 Mar 30.

    Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.

    Source

    Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180, USA. wentmp@rpi.edu

    Abstract

    A series of 7,8- and 8,9-fused pyrimidinone, aminopyrimidine and pyridone derivatives of 8-carboxamidocyclazocine (8-CAC) have been prepared and evaluated in opioid receptor binding assays. Targets were designed to corroborate a pharmacophore hypothesis regarding the bioactive conformation of the carboxamide of 8-CAC. In addition to the results from this study strongly supporting this pharmacophore hypothesis, a number of novel compounds with high affinity to opioid receptors have been identified.

    PMID:
    18417347
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2441872
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Scheme 4
    Scheme 2
    Scheme 3
    Scheme 5
    Scheme 1

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk